HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Hereditary Cancer Syndromes: Genetic counseling and testing strategies.

Hereditary cancer syndromes require targeted genetic counseling and testing strategies to identify those at increased risk. Through testing for mutations in key genes such as BRCA1/2, Lynch syndrome, and others, individuals can better understand their inherited risks for cancers like breast, ovarian, colorectal, and others. Genetic counseling provides essential information about the likelihood of developing cancer and available preventive measures, such as regular screenings, medications, or even prophylactic surgeries. Family members of those affected can also be tested to assess their risk. The integration of genetic testing with advanced technologies allows for more comprehensive care, enabling early detection, and reducing the cancer burden for future generations.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp